TC
TEVA icon

Tejara Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Tejara Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78,500
Closed -$1.32M – 73
2025
Q2 		$1.32M Sell
78,500
-102,300
-57% -$1.65M 0.61% 47
2025
Q1 		$2.78M Buy
+180,800
New +$3.23M 1.07% 28
2024
Q3 		– Sell
-418,588
Closed -$6.8M – 73
2024
Q2 		$6.8M Sell
418,588
-361,618
-46% -$5.57M 2.47% 15
2024
Q1 		$11M Sell
780,206
-275,800
-26% -$3.48M 4.05% 6
2023
Q4 		$11M Buy
1,056,006
+233,511
+28% +$2.18M 4.62% 3
2023
Q3 		$8.39M Buy
822,495
+293,900
+56% +$2.74M 4.76% 5
2023
Q2 		$3.98M Buy
+528,595
New +$4.29M 1.96% 15

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Tejara Capital's TEVA Position: Q3 2025 in Review

Tejara Capital sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 78,500 shares — an estimated $1.32M sold.

Tejara Capital first reported a position in TEVA in Q2 2023 and held it in 7 quarters. The position peaked at $11M in Q4 2023. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Tejara Capital reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Tejara Capital sold 78,500 Teva Pharmaceuticals shares in Q3 2025, an estimated $1.32M.
  • Tejara Capital first reported a position in Teva Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Tejara Capital's Teva Pharmaceuticals position peaked at $11M in Q4 2023.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Tejara Capital's 13F filing for Q3 2025, filed 4 Nov 2025.